Axsome Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	270.6	50.04	0	0	0	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	440.80%	-	-	-	-	-	-	-	-	-	Upgrade
Cost of Revenue	26.07	5.2	0	0	0	0	0	0	0	0	Upgrade
Gross Profit	244.54	44.84	0	0	0	0	0	0	0	0	Upgrade
Selling, General & Admin	323.12	159.25	66.65	28.9	13.6	9.35	7.21	6.34	2.42	1.39	Upgrade
Research & Development	97.94	57.95	58.06	70.24	53.65	23.5	19.96	21.2	6.78	4.28	Upgrade
Other Operating Expenses	55.29	7.44	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	476.36	224.64	124.71	99.14	67.25	32.85	27.16	27.54	9.2	5.67	Upgrade
Operating Income	-231.83	-179.8	-124.71	-99.14	-67.25	-32.85	-27.16	-27.54	-9.2	-5.67	Upgrade
Interest Expense / Income	6.45	7.34	5.7	2.57	1.24	1.13	1.34	0.13	0.74	0	Upgrade
Other Expense / Income	-	-	-	1.25	-	-2.79	0.65	-	2.28	0.51	Upgrade
Pretax Income	-238.28	-187.13	-130.4	-102.95	-68.48	-31.18	-29.15	-27.68	-12.21	-6.18	Upgrade
Income Tax	0.96	0	0	-0.05	-0.14	-0.22	-0.21	-0.47	0	-0.18	Upgrade
Net Income	-239.24	-187.13	-130.4	-102.9	-68.35	-30.97	-28.94	-27.2	-12.21	-6	Upgrade
Shares Outstanding (Basic)	45	41	38	37	34	27	23	19	12	9	Upgrade
Shares Outstanding (Diluted)	45	41	38	37	34	27	23	19	12	9	Upgrade
Shares Change	11.73%	8.07%	1.11%	9.37%	26.55%	18.09%	18.87%	60.32%	31.28%	18.32%	Upgrade
EPS (Basic)	-5.27	-4.60	-3.47	-2.77	-2.01	-1.15	-1.27	-1.42	-1.02	-0.66	Upgrade
EPS (Diluted)	-5.27	-4.60	-3.47	-2.77	-2.01	-1.15	-1.27	-1.42	-1.02	-0.66	Upgrade
Free Cash Flow	-145.66	-117.21	-108.53	-78.5	-46.39	-30.09	-26.48	-21.39	-7.46	-4.6	Upgrade
Free Cash Flow Per Share	-3.21	-2.88	-2.88	-2.11	-1.36	-1.12	-1.16	-1.12	-0.62	-0.51	Upgrade
Gross Margin	90.37%	89.61%	-	-	-	-	-	-	-	-	Upgrade
Operating Margin	-85.67%	-359.33%	-	-	-	-	-	-	-	-	Upgrade
Profit Margin	-88.41%	-373.99%	-	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-53.83%	-234.25%	-	-	-	-	-	-	-	-	Upgrade
EBITDA	-223.54	-174.24	-123.55	-100.31	-67.21	-30.01	-27.77	-27.52	-11.47	-6.18	Upgrade
EBITDA Margin	-82.61%	-348.21%	-	-	-	-	-	-	-	-	Upgrade
Depreciation & Amortization	8.28	5.56	1.16	0.08	0.04	0.05	0.04	0.02	0	0	Upgrade
EBIT	-231.83	-179.8	-124.71	-100.39	-67.25	-30.06	-27.81	-27.54	-11.47	-6.18	Upgrade
EBIT Margin	-85.67%	-359.33%	-	-	-	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).